DSM-Firmenich AG is a company limited by shares incorporated under the laws of Switzerland and listed on the Euronext Amsterdam stock exchange, a regulated market operated by Euronext Amsterdam N.V. In addition to our ordinary shares, options on ordinary DSM-Firmenich AG shares are traded on Euronext Amsterdam in the Netherlands.
dsm-firmenich shares are held via Euroclear and SIX SIS. Investors can hold shares via either Euroclear Nederland or SIX SIS. However, in order to trade shares on Euronext Amsterdam, investors must settle via Euroclear Nederland. This means shares will need to be held via Euroclear Nederland.
DSM- Firmenich AG has established a new sponsored Level I program with Deutsche Bank, appointed as depositary bank on December 21, 2023 and began trading as DSFIY on OTC.
As of April 4, 2024, DSM Firmenich AG was upgraded to OTCQX® Best Market. To qualify for OTCQX, companies must meet high financial standards, follow best practice corporate governance and demonstrate compliance with applicable securities laws. U.S. investors can find current financial disclosure and Real-Time Level 2 quotes for the company on www.otcmarkets.com.
About DSM Firmenich AG
DSM-Firmenich AG is a leading innovator in nutrition, health, and beauty. It reinvents, manufactures, and combines vital nutrients, flavors, and fragrances for the world's growing population to thrive. With a comprehensive range of natural and renewable ingredients and renowned science and technology capabilities, the company uniquely works to create what is essential for life, desirable for consumers, and more sustainable for the planet.
About OTC Markets Group Inc.
OTC Markets Group Inc. (OTCQX: OTCM) operates regulated markets for trading 12,000 U.S. and international securities. Our data-driven disclosure standards form the foundation of our three public markets: OTCQX® Best Market, OTCQB® Venture Market and Pink® Open Market.
On 6 May 2025, the Annual General Meeting of DSM-Firmenich AG adopted the proposal that a dividend per ordinary share was declared in the amount of EUR 2.50. The dividend was paid on 16 May 2025, partially (57.5%) out of capital contributions reserves and partially (42.5%) out of available earnings.
Each year at the Annual General Meeting of Shareholders dsm- firmenich requests approval for the Company to repurchase its own shares. dsm-firmenich regularly conducts share buy-back programs to cover its commitments under share-based compensation plans.
Check out or frequently asked questions page about our shares.
Whether you’re a shareholder, potential shareholder, or analyst, our Investor relations team is on hand to answer your questions.
Tools to track your share performance.
dsm-firmenich bonds, other debt, credit facilities and credit ratings.
Be the first to know about key news as we continue shaping the future and bringing progress to life.
